Literature DB >> 19017177

Inflammatory cells and immune microenvironment in malignant lymphoma.

D de Jong1, G Enblad.   

Abstract

It has become clear that the biological and clinical behaviour of malignant lymphoma is not only determined by the properties of the tumour cells themselves but are also largely by the interaction of the tumour cells with their nonmalignant microenvironment. The composition and functional status of the tumour microenvironment is highly variable between different classes of malignant lymphoma and may provide both growth-supportive and growth suppressive signals via components of the adaptive and innate immune response. In this review, the functional interactions and clinical consequences of these insights are discussed in indolent and aggressive B-cell lymphomas and in classical Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017177     DOI: 10.1111/j.1365-2796.2008.02032.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

Review 2.  Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions.

Authors:  Koichi Ohshima; Daisuke Niino; Kennosuke Karube
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

3.  Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients.

Authors:  Xin Huang; Anke van den Berg; Zifen Gao; Lydia Visser; Ilja Nolte; Hans Vos; Bouke Hepkema; Wierd Kooistra; Sibrand Poppema; Arjan Diepstra
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

4.  The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma.

Authors:  Aashiyana F Koreishi; Adam J Saenz; Dan O Persky; Hayan Cui; Allison Moskowitz; Craig H Moskowitz; Julie Teruya-Feldstein
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-05

5.  Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.

Authors:  Cecilia Carpio; Reda Bouabdallah; Loïc Ysebaert; Juan-Manuel Sancho; Gilles Salles; Raul Cordoba; Antonio Pinto; Mecide Gharibo; Drew Rasco; Carlos Panizo; Jose A Lopez-Martin; Armando Santoro; Antonio Salar; Silvia Damian; Alejandro Martin; Gregor Verhoef; Eric Van den Neste; Maria Wang; Suzana Couto; Soraya Carrancio; Andrew Weng; Xuehai Wang; Frank Schmitz; Xin Wei; Kristen Hege; Matthew W B Trotter; Alberto Risueño; Tonia J Buchholz; Patrick R Hagner; Anita K Gandhi; Michael Pourdehnad; Vincent Ribrag
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

6.  Microenvironment-centred dynamics in aggressive B-cell lymphomas.

Authors:  Matilde Cacciatore; Carla Guarnotta; Marco Calvaruso; Sabina Sangaletti; Ada Maria Florena; Vito Franco; Mario Paolo Colombo; Claudio Tripodo
Journal:  Adv Hematol       Date:  2012-02-19

7.  An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.

Authors:  Xiao-Jie Liang; Rui-Ying Fu; He-Nan Wang; Jing Yang; Na Yao; Xin-di Liu; Liang Wang
Journal:  J Immunol Res       Date:  2021-06-08       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.